scroll to top

EBSCO Auth Banner

Let's find your institution. Click here.

Calculating the affordability of antiretrovirals in St Lucia.

  • Academic Journal
  • Reddock JR; Health Policy PhD Programme, McMaster University, Hamilton, Canada.
    Grignon M; Centre for Health Economics, McMaster University, Hamilton, Canada.
  • The West Indian medical journal [West Indian Med J] 2013; Vol. 62 (4), pp. 350-6.
  • English
  • The cost of antiretrovirals is borne by donors in many low- and middle-income countries, including St Lucia. Although donor involvement has facilitated access to antiretrovirals, donor engagement in HIV/AIDS has changed over the years. This paper assesses the affordability of antiretrovirals at the individual level if donors were no longer available to fund the cost of first and second-line antiretrovirals and a prospective third-line regimen. Various conceptions of affordability are reviewed using different assumptions of what is required to maintain a standard of living that would avoid individuals descending into poverty as a result of antiretroviral purchases. These concepts of affordability are operationalized using data from the Household Budgeting Survey conducted in St Lucia in 2005/2006. While there is a range of results for the affordability of first and second-line antiretrovirals depending on which standard of affordability is used, third-line antiretrovirals are unaffordable to more than 80% of the population across the four standards of affordability used - the national poverty line, 50% of median annual consumption, 10% of annual consumption and a proposed reasonable minimum standard.
Additional Information
Publisher: The University of the West Indies Country of Publication: Jamaica NLM ID: 0417410 Publication Model: Print Cited Medium: Print ISSN: 0043-3144 (Print) Linking ISSN: 00433144 NLM ISO Abbreviation: West Indian Med J Subsets: MEDLINE
Publication: Kingston, Jamaica : The University of the West Indies
Original Publication: Mona, Jamaica, University College of the West Indies.
0 (Anti-Retroviral Agents)
Date Created: 20140424 Date Completed: 20140529 Latest Revision: 20170123